Necrosis Factor News Today

A widening array of medications has changed the course of disease

Houston, TX, June 8, 2023 - (ACN Newswire) - Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing multiple therapeutic programs intended to

Houston, TX, June 8, 2023 - (ACN Newswire) - Coya Therapeutics, Inc. (NASDAQ: COYA) ('Coya' or the 'Company'), a clinical-stage biotechnology company developing multiple therapeutic programs intended to enhance Treg function, including ...

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimers Disease

Data Bridge Market Research analyses that the biologics market was valued at USD 264 billion in 2021 and is expected to reach USD 596.65 billion by 2029,...

CD14 and TRIF are found to help with the treatment of sepsis potentially. Researchers have made a significant breakthrough that can help with the treatment of sepsis, as reported by Interesting Engineering.

According to the latest market report published by Credence Research, Inc. “Psoriasis Treatment  Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025” the global Psoriasis Treatment  market was valued at US$ 7.9 Bn in 2016, and is expected to reach US$ 12.8 Bn by 2025, expanding at a CAGR of  5.4% from 2017 to 2025. Market Insights Psoriasis is a chronic, inflammatory, painful skin disease for which there is no cure with great negative impact on patient�...

/PRNewswire/ -- The "Axial Spondyloarthritis Market - A Global and Country Analysis: Focus on Commercialized Therapies, Potential Pipeline Products,...

/PRNewswire/ -- The "Psoriasis Drugs Market Research Report by Therapeutic Class, Type of Treatment, Mechanism of Action, Route of Administration, Distribution...